Evaluating iCell Cardiomyocytes on the xCELLigence System Madison, Wisc. – Cellular Dynamics International (CDI) announced today their partnership with ACEA Biosciences to bring early and accurate prediction of potential cardiotoxic side effects to the drug discovery process. The partnership combines CDI’s induced pluripotent stem cell (iPSC)-derived heart cells, iCell™ Cardiomyocytes, with the xCELLigence™ RTCA System. […]
ec23 enables consistent and reliable differentiation of stem cells to neurons LGC Standards is delighted to announce the addition of ec23®, a stable synthetic retinoid used for stem cell differentiation, to its portfolio of life science research and drug discovery products. ec23 is a proprietary molecule designed by the scientists at Reinnervate, an innovative life […]
New Global Licensing Program Opens Access to Innovative Technologies CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ:LIFE) today announced that it has finalized cell line license agreements with a number of companies to provide rights to Life Technologies’ proprietary CHO (Chinese hamster ovary) cell lines for the production of recombinant proteins used as therapeutic agents and […]
Sunnyvale, Calif. – Molecular Devices, Inc. today announced the launch of its new corporate website. The infrastructure of the new site is focused on its three main audience segments: Drug Discovery Scientists (BioPharma), Life Science Researchers (BioResearch), and Bioassay/Test Developers (BioTesting). Molecular Devices has a singular focus on helping its customers-both existing and prospective–succeed. This […]
Tools to Study Genomic Instability and Genotoxic Stress Trevigen, Inc. is pleased to announce the availability of nineteen DNA repair gene knockdown cell lines, encompassing the Base Excision Repair pathway. These are target specific LN428 glioblastoma shRNA lentivirus transduced cells that are rigorously qualified and mycoplasma free. The percent knockdown levels range from 75% to […]
Cell line offering will complement assays for one-stop-shop for GPCR research in U.S. Boston, MA and Hayward, CA – Cisbio U.S., Inc. (www.htrf.com), a member of IBA group and global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, and Multispan, Inc., which focuses exclusively on drug discovery […]
Strasbourg – Polyplus-transfection SA, which specializes in the development of innovative solutions for cellular and molecular biology research, announced today that Généthon, a not-for-profit biotherapy laboratory run by the French Muscular Dystrophy Association (AFM – Association Française contre les Myopathies) and which is financed by donations raised through the annual Téléthon, has selected Polyplus-transfection’s jetPEI(TM) […]
Paris – Cellectis (Alternext: ALCLS), the French genome engineering specialist, has announced today that it has acquired all the assets of Cyto Pulse Sciences Inc., a US-based company specializing in the development, manufacture and commercialization of electroporation technology and equipment. Electroporation is a very efficient way to allow molecules such as Meganucleases to enter any […]
Paris (France) and Burlington (Ontario, Canada) – Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), and Cedarlane, a leading supplier of high quality research reagents to the life science community, today announced that they will join forces for the distribution of Cellectis bioresearch’s research kits in Canada. The companies will […]
Tens of trillions of cells existing on and inside a person’s body could yield new insights about what makes people healthy and unhealthy GE researchers to apply DNA amplification method to enable the analysis of individual cells that have largely been unstudied NISKAYUNA, NY – Researchers from GE Global Research have been awarded a $538,000 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
